| DRUG WATCH |
|
| Year : 2012 | Volume
: 44
| Issue : 5 | Page : 656-658 |
First case of mirtazepine-induced Stevens-Johnson syndrome from India
Amit Bhasin, Anil Gurtoo, Latika Gupta, Gunjan Aggarwal
Department of Medicine, Lady Hardinge Medical College, New Delhi, India
Correspondence Address:
Amit Bhasin
Department of Medicine, Lady Hardinge Medical College, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.100411
A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were suggestive of Stevens-Johnson syndrome. This is a rare adverse effect of the newer generation antidepressant mirtazepine.
[FULL TEXT] [PDF]*
|
